← Back to Search

Brain Activity Monitoring for Epilepsy

N/A
Recruiting
Research Sponsored by Baylor College of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Male and female patients between 10 and 64 years of age
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 7-14 days of neural activity collection
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to understand how the brain creates and executes programs of action on the fly, without prior rehearsal.

Who is the study for?
This trial is for male and female epilepsy patients aged between 10 and 64 who are having intracranial electrodes placed for their condition. Participants must be able to understand instructions and concentrate well enough to respond correctly during tasks.
What is being tested?
The study is examining how the brain responds when creating new behaviors on-the-spot, focusing on specific brain areas: medial temporal lobe (MTL) and ventral prefrontal cortex (vPFC). It involves novel tasks, virtual reality environments, and direct brain stimulation.
What are the potential side effects?
Since this research involves recording from the brain with implanted electrodes, potential side effects may include discomfort at electrode sites, infection risk, or other complications related to neurosurgical procedures.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 10 and 64 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~7-14 days of neural activity collection
This trial's timeline: 3 weeks for screening, Varies for treatment, and 7-14 days of neural activity collection for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Behavioral performance (Accuracy as fraction of correct responses)
Neurophysiological activity (single-neuron activity in spikes/second)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Neuropace RNS DeviceExperimental Treatment1 Intervention
Patients are implanted with RNS device to treat their seizure activity
Group II: Epilepsy Monitoring UnitExperimental Treatment1 Intervention
Patient's behavioral and neural activity via computer tasks and questionnaires are monitored in the Epilepsy Monitoring Unit

Find a Location

Who is running the clinical trial?

Baylor College of MedicineLead Sponsor
1,023 Previous Clinical Trials
6,029,076 Total Patients Enrolled
4 Trials studying Epilepsy
162 Patients Enrolled for Epilepsy

Media Library

Epilepsy Monitoring Unit Clinical Trial Eligibility Overview. Trial Name: NCT05283811 — N/A
Epilepsy Research Study Groups: Epilepsy Monitoring Unit, Neuropace RNS Device
Epilepsy Clinical Trial 2023: Epilepsy Monitoring Unit Highlights & Side Effects. Trial Name: NCT05283811 — N/A
Epilepsy Monitoring Unit 2023 Treatment Timeline for Medical Study. Trial Name: NCT05283811 — N/A
~58 spots leftby Mar 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top